市場調查報告書
商品編碼
1452621
2030 年亞太地區醫療快遞市場預測 - 區域分析 - 按產品類型、目的地、服務和最終用戶Asia Pacific Medical Courier Market Forecast to 2030 - Regional Analysis - By Product Type, Destination, Service, and End Users |
2022年亞太醫療快遞市值為24.2629億美元,預計2030年將達到37.3517億美元;預計2022年至2030年CAGR為5.5%。
採用軸輻模式推動亞太醫療快遞市場
輪輻模型是一種類似自行車車輪結構的集中倉儲和運輸系統。輪子的中心是輪圈或配送中心,每條輻條代表一個配送方向。中心輻射模型更有正面的一面,是一種經濟高效的方法。該模型鼓勵將所有庫存整合到一個地方(中心),然後從那裡及時交付到不同區域(輻條)。中心輻射型配送模型允許規劃和最佳化圍繞中心連接到各個目的地的配送路線。產品被包裝、運送到一處,並在首選時間內運送到多個地點。與其他模型相比,它改善了勞動力並大大縮短了交貨時間。
此外,在首選物流合作夥伴的幫助下,商家可以集中控制庫存,從最便宜的供應商購買產品,並從當地倉庫將貨物運送給客戶。托運人可以透過將庫存集中在一個集中點來享受更實惠的價格。然後,可以將這些零擔貨物合併起來裝滿一卡車貨物,然後將其分散到整個網路中。中小型企業 (SMB) 可以透過協商獲得通常與使用此模式的整車運輸相關的更好費率。因此,上述中心輻射模型的所有好處以及 NHS 關於中心輻射模型的各種舉措將在未來幾年內支持歐洲醫療快遞市場。
亞太地區醫療快遞市場概況
亞太地區醫療快遞市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。在印度、日本和其他國家難以到達或地形複雜的地區,人們越來越意識到使用無人機運送疫苗和藥品等醫療用品,這有利於該地區亞太醫療快遞市場的成長。在印度,印度醫學研究委員會 (ICMR) 於 2022 年 1 月開展了一項有效轉移藥品、血包、診斷樣本和疫苗等醫療用品的培訓計劃。當ICMR 發起該計劃時,研究小組進行了一項兩階段研究,以評估無人機是否可以在印度表現良好。在第一階段研究中,ICMR 與印度理工學院坎普爾分校合作,他們分析說,無人機是一種有效且可靠的疫苗運輸方式,可實現預定的目標和路徑。在第二階段,ICMR 在現實生活中進行了一項研究,使用這些無人機在曼尼普爾邦和那加蘭邦運送醫療用品。在成功完成這兩項研究後,ICMR 開始培訓參與透過無人機運送醫療用品的人員,以進一步將他們與全民免疫計畫 (UIP) 聯繫起來。 2022 年 4 月,豐田通商公司和 Zipline 推出了日本第一條遠端無人機送貨路線。透過這條路線,這些公司將向日本偏遠的五島群島運送醫療用品(處方藥)。 Zipline 與澳洲新南威爾斯州政府合作,利用 Zipline 無人機向該州的醫院和其他醫療機構按需運送基本醫療用品。此外,2021 年 2 月,Swoop Aero 與連鎖藥局 TerryWhite Chemmart 簽署協議,在 Goondiwindi 市 130 公里範圍內運送藥品。 2021 年 2 月,北領地 (NT) 政府衛生部和查爾斯達爾文大學與 iMOVE 建立合作夥伴關係,資助一個專注於將無人機涵蓋北領地醫療保健的計畫。該專案旨在開發客製化醫療無人機,並試用它們在澳洲北領地運送藥品。因此,人們越來越認知和使用無人機在偏遠地區運送醫療用品,這正在推動亞太醫療快遞市場的成長。
亞太地區醫療快遞市場收入及 2030 年預測(百萬美元)
亞太地區醫療快遞市場區隔
亞太地區醫療快遞市場根據產品類型、目的地、服務、最終用戶和國家進行細分。
根據產品類型,亞太地區醫療快遞市場分為醫療用品和設備、血液和器官、實驗室標本、醫療筆記等。 2022年,醫療用品和設備領域佔最大佔有率。
按目的地分類,亞太地區醫療快遞市場分為國內和國際。 2022 年,國內市場佔更大佔有率。
按服務分類,亞太地區醫療快遞市場分為標準服務以及加急和按需服務。 2022 年,標準服務和加急服務將佔據更大佔有率。
就最終用戶而言,亞太地區醫療快遞市場分為醫院和診所、診斷實驗室、血液和組織庫、藥房、家庭支援、製藥和生物技術公司等。 2022 年,醫院和診所部門佔最大佔有率。
依國家/地區分類,亞太地區醫療快遞市場分為中國、印度、日本、韓國、澳洲和亞太地區其他地區。 2022年,中國在亞太醫療快遞市場佔據主導地位。
德國郵政股份公司、聯邦快遞公司、MNX 全球物流公司、聯合包裹服務公司和 Zipline 國際公司是亞太地區醫療快遞市場上的一些領先公司。
The Asia Pacific medical courier market was valued at US$ 2,426.29 million in 2022 and is expected to reach US$ 3,735.17 million by 2030; it is estimated to grow at a CAGR of 5.5% from 2022 to 2030.
Adoption of Hub and Spoke Model Fuels the Asia Pacific Medical Courier Market
A hub and spoke model is a centralized warehousing and shipment system similar to a bicycle wheel's structure. The center of the wheel is the hub or a distribution center, and each spoke represents a delivery direction. The hub-and-spoke model weighs more on the positive side of the spectrum and is a cost-effective and efficient approach. The model encourages consolidation of all the inventory in one place (hub), from where it is delivered timely to different areas (spokes). The hub-and-spoke distribution model allows for planning and optimizing delivery routes around the hub linking to various destinations. The product is packed, shipped to one place, and delivered to multiple locations within the preferred time. It improves the workforce and substantially reduces the delivery time compared to the other model.
In addition, with the help of preferred logistics partners, merchants can control inventory centrally, source products from the least expensive suppliers, and deliver goods to customers from local warehouses. Shippers can take advantage of more affordable rates by aggregating their inventory at a centralized point. This less-than-truckload shipment can then be combined to fill a single truckload which can then be dispersed throughout the network. Small-and-medium-sized businesses (SMBs) can negotiate for better rates often associated with full truckload shipments using this model. Thus, all the benefits mentioned above of the hub and spoke model and various initiatives by NHS regarding the hub and spoke model are going to support the Europe medical courier market in the coming years.
Asia Pacific Medical Courier Market Overview
The Asia Pacific medical courier market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Increasing awareness about the use of drones for the delivery of medical supplies such as vaccines and medicines in hard-to-reach or difficult terrain regions in India, Japan, and other countries is favoring the Asia Pacific medical courier market growth in this region. In India, the Indian Council of Medical Research (ICMR) conducted a training program for the effective transfer of medical supplies such as medicines, blood packages, diagnostic samples, and vaccines in January 2022. When the program was initiated by ICMR, the research groups carried out a two-phase study to evaluate if drones could perform well in India. In the Phase I study, ICMR collaborated with IIT-Kanpur, where they analyzed that drones are an effective and reliable mode of vaccine transportation for predefined objectives and paths. In Phase II, ICMR conducted a study in real-life settings by delivering medical supplies in the State of Manipur and Nagaland using these drones. After the successful completion of these two studies, ICMR started to train people involved in delivering medical supplies through drones to further associate them with the Universal Immunization Program (UIP). In April 2022, Toyota Tsusho Corporation and Zipline rolled out Japan's first long-distance drone delivery route. Through this route, the companies would deliver medical supplies (prescription drugs) to remote Goto Islands of Japan. Zipline has partnered with the Government of New South Wales, Australia, to facilitate an on-demand delivery of essential medical supplies to hospitals and other healthcare facilities in the state by using Zipline drones. In addition, in February 2021, Swoop Aero signed a deal with chemist chain TerryWhite Chemmart to deliver medicines within the 130 km range of Goondiwindi city. In February 2021, the Department of Health of the Northern Territory (NT) Government and Charles Darwin University entered into a partnership with iMOVE to fund a project that focuses on integrating drones into NT health. The project aimed to develop custom-made medical drones and trial them for the delivery of medicines in the Northern Territory of Australia. Hence, the increasing awareness and use of drones for the delivery of medical supplies in remote areas is fueling the growth of the Asia Pacific medical courier market.
Asia Pacific Medical Courier Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Medical Courier Market Segmentation
The Asia Pacific medical courier market is segmented based on product type, destination, service, end users, and country.
Based on product type, the Asia Pacific medical courier market is segmented into medical supplies and equipment, blood and organs, lab specimens, medical notes, and others. The medical supplies and equipment segment held the largest share in 2022.
By destination, the Asia Pacific medical courier market is bifurcated into domestic and international. The domestic segment held a larger share in 2022.
By service, the Asia Pacific medical courier market is bifurcated into standard service and rush and on-demand services. The standard service and rush segment held a larger share in 2022.
In terms of end users, the Asia Pacific medical courier market is categorized into hospital and clinics, diagnostic labs, blood and tissue banks, pharmacy, in home support, pharmaceutical and biotechnology companies, and others. The hospital and clinics segment held the largest share in 2022.
Based on country, the Asia Pacific medical courier market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific medical courier market in 2022.
Deutsche Post AG, FedEx Corp, MNX Global Logistics Corp, United Parcel Service Inc, and Zipline International Inc are some of the leading companies operating in the Asia Pacific medical courier market.